Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"340B program"”.

  1. The Design and Implementation of a 340B Program Effectiveness Dashboard

    Background: The 340B Drug Discount Program is a federal program enacted by Congress in 1992 that requires participating drug manufacturers to provide discounted prices on covered outpatient drugs to eligible covered entities that serve the country’s indigent and vulnerable patient populations. …

    houston Repository record for The Design and Implementation of a 340B Program Effectiveness Dashboard (opens in a new tab)

  2. The Incidence of the 340B Program: The Effects of Contract Pharmacies on Part D Premiums and Reimbursements

    … and patients enrolled in their plans. The 340B Program effectively taxes drug manufacturers by requiring them to provide large discounts on drugs purchased by safety-net providers. I assess to what degree insurer premiums are impacted by drug manufacturer pass-through of 340B discounts by …

    penn Repository record for The Incidence of the 340B Program: The Effects of Contract Pharmacies on Part D Premiums and Reimbursements (opens in a new tab)

  3. Funding the U.S. healthcare safety net: implications and opportunities of the 340B drug pricing program

    This dissertation examines the role of the 340B Drug Pricing Program in the US health care safety-net and its implications for access, affordability, and health equity. The 340B Program allows certain hospitals and public health clinics that serve a disproportionate share of low-income patients to …

    bu Repository record for Funding the U.S. healthcare safety net: implications and opportunities of the 340B drug pricing program (opens in a new tab)

  4. The 340B drug discount program: enrollment and participation among critical access hospitals

    The 340B Program is a federal program that provides certain healthcare safety-net providers mandated price reductions on outpatient drugs. In 2010, critical access hospitals (CAHs)--small hospitals in isolated rural communities--became eligible for the program. This project set forth to understand …

    umn Repository record for The 340B drug discount program: enrollment and participation among critical access hospitals (opens in a new tab)

  5. The Evolution Of Aids Service Organizations: The Impact Of The 340B Drug Pricing Program

    … and the impact of their participation in the 340B Drug Pricing Program. The research, grounded in the Resource-Based View (RBV) theory, explores how the 340B program as a unique organizational resource may lead to mission expansion and an increase in service offerings among ASOs. By comparing …

    uab Repository record for The Evolution Of Aids Service Organizations: The Impact Of The 340B Drug Pricing Program (opens in a new tab)

  6. The Impact Of The 340B Drug Pricing Program On Post-Launch Drug Prices

    … significant—factor in the price of drugs. The 340B program is one of the more controversial government-mandated prescription drug discount programs. Proponents argue that the program helps health care systems cover the cost of care they provide for low-income patients. Critics argue that the …

    nodak Repository record for The Impact Of The 340B Drug Pricing Program On Post-Launch Drug Prices (opens in a new tab)

  7. The 340B Drug Pricing Program: Are 340B Covered Entities Providing More Services and More Uncompensated Care?

    The 340B Drug Pricing Program enacted in 1992 requires pharmaceutical manufacturers participating in the Medicaid program to provide statutorily defined discounts on "covered outpatient drugs" purchased by government-supported facilities, known as covered entities, that are expected to serve the …

    uab Repository record for The 340B Drug Pricing Program: Are 340B Covered Entities Providing More Services and More Uncompensated Care? (opens in a new tab)

  8. The economics of safety-net programs: evidence from the 340B Drug Pricing Program

    … and Elizabeth Watts) studying the growth of the 340B Drug Pricing Program, a safety-net program that is responsible for nearly 10% of annual pharmaceutical spending in the United States. The two articles presented in this chapter are adapted from versions that have been published in JAMA Health …

    umn Repository record for The economics of safety-net programs: evidence from the 340B Drug Pricing Program (opens in a new tab)

  9. Evaluating Cost Savings and Patient Benefit from the 340B Drug Pricing Program through Expansion of Pediatric Outpatient Pharmacy Services

    PURPOSE: The 340B Drug Pricing Program was established in 1992 for covered entities to stretch Federal resources and provide eligible patients with comprehensive services. Pediatric hospitals were recognized as eligible for the 340B program in 2006. There are limited reports on expanding access to …

    houston Repository record for Evaluating Cost Savings and Patient Benefit from the 340B Drug Pricing Program through Expansion of Pediatric Outpatient Pharmacy Services (opens in a new tab)

  10. The impact of 340B disruption on patients with autoimmune rheumatic diseases

    … to purchase discounted drugs through the Federal 340B Drug Pricing Program. Originally, 340B pricing was restricted to in-house hospital pharmacies. In 1996, covered entities were permitted to contract with one outside pharmacy. This was expanded to any pharmacy starting in 2010, improving …

    umkc Repository record for The impact of 340B disruption on patients with autoimmune rheumatic diseases (opens in a new tab)

  11. Effects of the 340B Drug Pricing Program on Hospitals’ Prescribing Behavior, Patient Mix, and Quality of Care

    In 1992, Congress created the 340B Drug Pricing Program that requires drug manufacturers to provide outpatient drugs to participating hospitals with substantial discounts. Although the intent of the program is to allow covered entities to increase access to care for more vulnerable patients, …

    usf Repository record for Effects of the 340B Drug Pricing Program on Hospitals’ Prescribing Behavior, Patient Mix, and Quality of Care (opens in a new tab)